A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Erasca, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 10,218 shares of ERAS stock, worth $28,406. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,218
Previous 7,758 31.71%
Holding current value
$28,406
Previous $18,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$2.17 - $3.28 $5,338 - $8,068
2,460 Added 31.71%
10,218 $27,000
Q2 2024

Jul 30, 2024

BUY
$1.79 - $2.63 $13,886 - $20,403
7,758 New
7,758 $18,000
Q4 2022

Feb 09, 2023

BUY
$3.89 - $8.57 $190 - $419
49 Added 0.17%
29,704 $128,000
Q3 2022

Nov 10, 2022

BUY
$5.82 - $10.68 $48,131 - $88,323
8,270 Added 38.67%
29,655 $232,000
Q2 2022

Jul 26, 2022

BUY
$4.58 - $8.72 $97,943 - $186,477
21,385 New
21,385 $119,000

Others Institutions Holding ERAS

About Erasca, Inc.


  • Ticker ERAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 122,147,000
  • Market Cap $340M
  • Description
  • Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; ...
More about ERAS
Track This Portfolio

Track Mirae Asset Global Investments Co., Ltd. Portfolio

Follow Mirae Asset Global Investments Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.